Showing 321 - 340 results of 1,290 for search '(( 10 i decrease ) OR ( 50 ((((ng decrease) OR (mean decrease))) OR (nn decrease)) ))', query time: 0.17s Refine Results
  1. 321
  2. 322
  3. 323

    The spectral and morphological studies of the conductive polyaniline thin film derivatives by the in situ copolymerization by Waware, Umesh S.

    Published 2017
    “…The particle size varies in the range of 5–10,000 nm for polyaniline while in case of copolymer it lies in a narrow range of 100–150.…”
    Get full text
    Get full text
  4. 324
  5. 325
  6. 326
  7. 327
  8. 328
  9. 329
  10. 330
  11. 331

    Study of the effects of dust, relative humidity, and temperature on solar PV performance in Doha: Comparison between monocrystalline and amorphous PVS by Touati F.A.

    Published 2013
    “…It was estimated that 100 days of dust accumulation over monocrystalline PV panels, caused the efficiency to decrease by around 10%. This limitation makes solar PVs to represent an unreliable source of power for unattended or remote devices and thus strongly suggests the challenge of cleaning the panel's surface regularly or injecting technical modifications. …”
    Get full text
    Get full text
  12. 332
  13. 333
  14. 334
  15. 335
  16. 336

    Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 by Stein Emil, Vollset

    Published 2024
    “…In the assessment of alternative future scenarios, the combined effects of the scenarios (Safer Environment, Improved Childhood Nutrition and Vaccination, and Improved Behavioural and Metabolic Risks scenarios) demonstrated an important decrease in the global burden of DALYs in 2050 of 15·4% (13·5–17·5) compared with the reference scenario, with decreases across super-regions ranging from 10·4% (9·7–11·3) in the high-income super-region to 23·9% (20·7–27·3) in north Africa and the Middle East. …”
    Get full text
    Get full text
    Get full text
  17. 337

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  18. 338

    Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 by Stein Emil, Vollset

    Published 2024
    “…In the assessment of alternative future scenarios, the combined effects of the scenarios (Safer Environment, Improved Childhood Nutrition and Vaccination, and Improved Behavioural and Metabolic Risks scenarios) demonstrated an important decrease in the global burden of DALYs in 2050 of 15·4% (13·5–17·5) compared with the reference scenario, with decreases across super-regions ranging from 10·4% (9·7–11·3) in the high-income super-region to 23·9% (20·7–27·3) in north Africa and the Middle East. …”
    Get full text
    Get full text
    Get full text
    article
  19. 339
  20. 340